A pilot randomized study comparing Blumea balsamifera (sambong) and terpenes on ureteroli thiasis

Rommel  P. Bataclan,; Tennille  Tan,

A pilot randomized study comparing Blumea balsamifera (sambong) and terpenes on ureteroli thiasis

Abstract:

Introduction Alternative agents have been proposed for the management of kidney or ureteral stones. This study aimed to investigate the safety and efficacy of Blumea balsamifera (sambong) compared with a terpene combination drug as treatment for ureterolithiasis. Methods Patients with clinically stable kidney function and ureteral stones of ? 5 mm were randomized to receive a special terpene combination (Rowatiriex®) or Blumea balsamifera. All patients had a physical examination, and diagnosis of kidney stones was made by ultrasound at baseline and after 6 and 12 weeks of treatment. Primary outcomes were change in stone size and stone-free status, defined as obviously successful expulsion of calculi/fragments, documented by ultrasound. Results After 6 weeks, five patients in the sambong group and six in the terpene group were stone free (p = 0.90). After 12 weeks, seven in the sambong and eight in the terpene group were stone free (p = 0.31). In terms of s tone size, there was a significant decrease in the mean diameter in the sambong group (l.81 ± 2.01 mm, p = 0.008 and l.12 ± 1.43 mmp < 0.005) and in the terpene group (1.24 ± 1.43 mm p<0.005 and 0.74 ± 0.70 mm, p<0.005) at 6 and 12 weeks, respectively. However, there was no significant difference between the two groups. Urine pH also increased in both groups compared to baseline but the difference was not statistically significant when comparing the two arms. Conclusion Blumea balsamifera is comparable with a terpene combination in the dissolution of urolithiasis and is well-tolerated and safe.

References:

Sohgaura A, Bigoniya P. A review on the epidemiology and etiology of renal stones. Am J Drug Disc Devt 2017; 7: 54-62
Uy NT, Lapitan MCM, Gatchalian ER. The epidemiology of urinary stones in a tertiary government hospital. Phil J Uro12008; 18(2): 334-40.
Halili ERM, Garcia LA, Bernardo PMJ. Comparative study on the urinary citrate levels in Filipino stone formers versus non-stone formers Phil J Uro1 2009; 19(2): 172-7.
Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R. An update and practical guide to renal stone management. Nephron Clin Pract 2010; 166: c159-c7l.
Bach T. Preclinical and clinical overview of terpenes in the treatment of urolithiasis. Euro Urol Supp 2010; 9: 814-8.
Engelstein D, Kahan E, Servadio C. Rowatinex for the treatment of ureterolithiasis. J Urol 1992; 98: 98-100.
Aldemir M, Ucgul E, Kayigil D. Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study. Int Urol Nephrol 2011; 43(1): 79-83.
Djaladat K. Mahouri K, Khalifeh Shooshtary F, Ahmadieh A. Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy. Urol J 2009; 6(1): 9-13.
Kim DH, Goh HJ, Lee WH, Kim KS, Kim YT. The effect of terpene combination on ureter calculus expulsion after ESWL. Korean J Urol 2014; 55: 36-40.
Ahmed S, Hasa MM, Mahmood ZA. Anti-urolithiatic plants in different countries and cultures. J Pharmacognosy Phytochem 2016; 5(1): 102-15.
De Leon D, Maramba NC. Phase II clinical trial of sambong tablet as diuretic. 1984. Unpublished manuscript. UP-Philippine General Hospital.
Sigua H. Molina MC. Blumea balsamifera (sambong) for the treatment of urinary tract stone: Randomized, double-blind, placebo controlled study. 1991. (Unpublished) UP-Philippine General Hospital.
Purificacion J, Maramba NC. Phase III clinical trial of Blumea balsafimera (sambong) tablet in the treatment of urinary tract stones. The Filipino Family Physician 1994; 33(1): 17-25.
Bernaldo EC, Diwa HA, Marcelo AA, Paps SH, Montemayor ES, Dimacali CTD. Comparison of renal stone dissolution effects between potassium citrate and sambong (Blumea balsamifera): A randomized open label study. Phil J Nephrol 2007; 23 (1): 39-43.
Montealegre CM, Ilao AC, Mendoza RVT, Carpio RPM, De Leon RL. Effect of Blumea balsamifera extract in kinetics of calcium oxalate crystallization. Chem Eng Transact 2017; 56: 1633-8.
Pang Y, Wang D, Fan Z, Chen Y, Yu F. Blumea balsamifera: A phytochemical and pharmacological review. Molecules 2014; 19: 9453-7.
Apaya KL, Hernandez CLC. Xanthine oxidaseinhibition of selected Philippine medicinal plants. J Med Plants Res 2011; 5(2): 289-92.
European Association of Urology. Guidelines on Urolithiasis. 2015. Available from: http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR_full.pdfAugust 2017